SP Asset Management’s Biogen BIIB Stock Holding History

SP Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,620	Closed	-$701K	–	98
2020 Q2	$701K	Buy	2,620 +1,310	+100%	+$394K	0.15%	53
2020 Q1	$414K	Hold	1,310	–	–	0.11%	59
2019 Q4	$389K	Hold	1,310	–	–	0.09%	61
2019 Q3	$305K	Hold	1,310	–	–	0.08%	63
2019 Q2	$306K	Hold	1,310	–	–	0.08%	61
2019 Q1	$310K	Hold	1,310	–	–	0.08%	60
2018 Q4	$394K	Hold	1,310	–	–	0.12%	56
2018 Q3	$437K	Hold	1,310	–	–	0.12%	54
2018 Q2	$443K	Buy	+1,310	New	+$368K	0.12%	54

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SP Asset Management's BIIB Position: Q3 2020 in Review

SP Asset Management sold out of Biogen (BIIB) in Q3 2020, closing a stake of 2,620 shares — an estimated $701K sold.

SP Asset Management first reported a position in BIIB in Q2 2018 and held it in 9 quarters. The position peaked at $701K in Q2 2020. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

SP Asset Management reported no remaining Biogen position as of Q3 2020 after selling out during the quarter.
SP Asset Management sold 2,620 Biogen shares in Q3 2020, an estimated $701K.
SP Asset Management first reported a position in Biogen in Q2 2018 and held it in 9 quarters.
SP Asset Management's Biogen position peaked at $701K in Q2 2020.
1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on SP Asset Management's 13F filing for Q3 2020, filed 6 Nov 2020.